Daewon, Samyang to strengthen co-development of new drugs

Published: 2008-06-13 06:52:00

Updated: 2008-06-13 06:52:00

Daewon Pharm signed a memorandum of understanding with Samyang Corporation to jointly develop three new tranquilizers using Samyang’s fast dissolving tablet (FDT; also called “orally dsintegrating tablet”) technology.

Fast Dissolving Tablets can be dissolved in the mouth rapidly without admini...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK